The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.

The research team will analyze existing genome-wide association study data and RNA sequencing to compare fibroid development patterns in Nigerian women and U.S. Black women, which could point to targeted therapies and management strategies for affected women.

The All of Us Research Program brings the future of health to VUMC and Nashville. 

Ellis is a computational geneticist with a long-term goal of bridging genomics, bioethics and health policy to promote equitable precision medicine for minority populations.

VUMC researchers have developed a genetic method that clusters distantly related people to find rare variants that were present in a common ancestor.

Bick will succeed Nancy Cox, PhD, who has led Genetic Medicine since she came to VUMC in 2015. Genetic Medicine is one of 13 divisions in the Department of Medicine.

A real-world learning health system was established at VUMC a decade ago. Now, the National Human Genome Research Institute is awarding two five-year grants totaling $12 million to support VUMC’s participation in, and coordination of, a genomic-enabled learning health system (gLHS) network.